1,401,923 filings since 2004 · latest accepted Nov 3, 2026, 5:27 PM ET
Priority items usually mark a change in credit, accounting integrity, control or listing status: 1.02 Agreement terminated, 1.03 Bankruptcy, 1.05 Cybersecurity incident, 2.04 Debt acceleration, 2.05 Restructuring costs, 2.06 Impairment, 3.01 Delisting notice, 4.01 Auditor change, 4.02 Non-reliance (restatement), 5.01 Change in control.
| Filed | Company | Items | Filing |
|---|---|---|---|
Oct 1, 2026 accepted 6:09 PM ET | CNBXCNBX Pharmaceuticals Inc. | 4.01Auditor change | DocumentSEC ↗ |
Mar 22, 2024 accepted 12:51 PM ET | CNBXCNBX Pharmaceuticals Inc. | 4.01Auditor change | Document |
Source: SEC EDGAR. Same-day filings appear within minutes and are re-checked against SEC's nightly index. Tickers are current listings, so a company's older filings show its ticker today.
Nov 7, 2019 accepted 10:13 PM ET | CNBXCNBX Pharmaceuticals Inc. | 4.01Auditor change | DocumentSEC ↗ |
Jul 23, 2019 accepted 5:45 PM ET | CNBXCNBX Pharmaceuticals Inc. | 4.01Auditor change | DocumentSEC ↗ |
Nov 13, 2017 accepted 8:21 PM ET | CNBXCNBX Pharmaceuticals Inc. | 4.01Auditor change | DocumentSEC ↗ |
Mar 22, 2016 accepted 9:17 PM ET | CNBXCNBX Pharmaceuticals Inc. | 4.01Auditor change | DocumentSEC ↗ |
Nov 17, 2011 accepted 7:09 PM ET | CNBXCNBX Pharmaceuticals Inc. | 8-K/A 4.01Auditor change | DocumentSEC ↗ |
Nov 14, 2011 accepted 6:16 PM ET | CNBXCNBX Pharmaceuticals Inc. | 4.01Auditor change | DocumentSEC ↗ |
Jun 29, 2011 accepted 8:51 PM ET | CNBXCNBX Pharmaceuticals Inc. | 4.01Auditor change | DocumentSEC ↗ |